MICHAEL BRAUN to Female
This is a "connection" page, showing publications MICHAEL BRAUN has written about Female.
Connection Strength
0.546
-
Fetal Nephrology: A Quaternary Care Center Experience. Kidney360. 2023 03 01; 4(3):333-340.
Score: 0.030
-
Hemolytic uremic syndrome as the presenting manifestation of WT1 mutation and Denys-Drash syndrome: a case report. BMC Nephrol. 2017 Jul 18; 18(1):243.
Score: 0.020
-
Defining and predicting 'intrauterine fetal renal failure' in congenital lower urinary tract obstruction. Pediatr Nephrol. 2016 Apr; 31(4):605-12.
Score: 0.018
-
Long-term outcome of renal transplantation patients with Henoch-Schonlein purpura. Clin J Am Soc Nephrol. 2011 Aug; 6(8):2034-40.
Score: 0.013
-
Allograft failure in kidney transplant recipients with membranoproliferative glomerulonephritis. Am J Kidney Dis. 2011 Feb; 57(2):291-9.
Score: 0.013
-
Urine proteome analysis in murine nephrotoxic serum nephritis. Am J Nephrol. 2009; 30(5):450-8.
Score: 0.012
-
Maintaining oxaliplatin therapy after hypersensitivity reactions: real-world experience with a desensitisation protocol. Clin Exp Med. 2026 Jan 21; 26(1):118.
Score: 0.009
-
Exploring perceptual disparities: A study on the level of understanding of colorectal cancer care among patients and healthcare professionals. Int J Colorectal Dis. 2026 Jan 08; 41(1):22.
Score: 0.009
-
Multiomic Factor Analysis for Pathologic Complete Response after Pembrolizumab + Trastuzumab + Pertuzumab in HER2-Enriched Early Breast Cancer: WSG-Keyriched-1 Trial. Clin Cancer Res. 2026 Jan 06; 32(1):214-223.
Score: 0.009
-
A clinical rule-based indicator to identify recurrence of colorectal cancer after curative resection using linked routinely collected national data. Cancer Epidemiol. 2026 Feb; 100:102962.
Score: 0.009
-
Overall Survival for Bevacizumab Therapy in Metastatic Colorectal Cancer: An Updated Analysis of the TRAVASTIN Study. Clin Colorectal Cancer. 2026 03; 25(1):115-124.
Score: 0.009
-
C5a receptor deficiency attenuates T cell function and renal disease in MRLlpr mice. J Am Soc Nephrol. 2005 Dec; 16(12):3572-82.
Score: 0.009
-
Recurrence of membranoproliferative glomerulonephritis type II in renal allografts: The North American Pediatric Renal Transplant Cooperative Study experience. J Am Soc Nephrol. 2005 Jul; 16(7):2225-33.
Score: 0.009
-
Chemotherapy-free neoadjuvant pembrolizumab combined with trastuzumab and pertuzumab in HER2-enriched early breast cancer (WSG-KEYRICHED-1): a single-arm, phase 2 trial. Lancet Oncol. 2025 May; 26(5):629-640.
Score: 0.009
-
Immunomodulatory gene networks predict treatment response and survival to de-escalated, anthracycline-free neoadjuvant chemotherapy in triple-negative breast cancer in the WSG-ADAPT-TN trial. Mol Cancer. 2025 Mar 26; 24(1):96.
Score: 0.009
-
Value of hospital administrative data linked to national cancer registry records to identify metastatic disease at time of primary diagnosis in colorectal cancer patients: a study using national data in England. BMC Cancer. 2025 Mar 06; 25(1):407.
Score: 0.009
-
HER2-low status as a distinct breast cancer subtype: myth or truth? Analysis of the WSG trials WSG-ADAPT-HR+/HER2-, WSG-PlanB, and WSG-ADAPT-TN. Breast Cancer Res. 2025 Feb 14; 27(1):22.
Score: 0.008
-
Genetic Alterations, Therapy Response, and Survival Among Patients With Triple-Negative Breast Cancer: A Secondary Analysis of a Randomized Clinical Trial. JAMA Netw Open. 2025 02 03; 8(2):e2461639.
Score: 0.008
-
Oncological Outcomes From Cytoreductive Surgery and Heated Intraperitoneal Chemotherapy for Colorectal Cancer Peritoneal Metastases. Clin Colorectal Cancer. 2025 06; 24(2):166-179.
Score: 0.008
-
Longitudinal Follow-Up of the Psychological Well-Being of Patients with Colorectal Cancer: Final Analysis of PICO-SM. Curr Oncol. 2024 12 11; 31(12):7903-7913.
Score: 0.008
-
Is early-onset colorectal cancer an evolving pandemic? Real-world data from a tertiary cancer center. Oncologist. 2024 12 06; 29(12):e1680-e1691.
Score: 0.008
-
Fetal bladder morphology as a predictor of outcome in fetal lower urinary tract obstruction. Prenat Diagn. 2024 02; 44(2):124-130.
Score: 0.007
-
De-Escalated Neoadjuvant Trastuzumab-Emtansine With or Without Endocrine Therapy Versus Trastuzumab With Endocrine Therapy in HR+/HER2+ Early Breast Cancer: 5-Year Survival in the WSG-ADAPT-TP Trial. J Clin Oncol. 2023 08 01; 41(22):3796-3804.
Score: 0.007
-
Impact of RNA Signatures on pCR and Survival after 12-Week Neoadjuvant Pertuzumab plus Trastuzumab with or without Paclitaxel in the WSG-ADAPT HER2+/HR- Trial. Clin Cancer Res. 2023 02 16; 29(4):805-814.
Score: 0.007
-
Association of Quality and Technology With Patient Mobility for Colorectal Cancer Surgery. JAMA Surg. 2023 01 01; 158(1):e225461.
Score: 0.007
-
Genetic diagnosis and renal biopsy findings in the setting of a renal genetics clinic. Am J Med Genet C Semin Med Genet. 2022 09; 190(3):302-308.
Score: 0.007
-
Impact of stromal tumor-infiltrating lymphocytes (sTILs) on response to neoadjuvant chemotherapy in triple-negative early breast cancer in the WSG-ADAPT TN trial. Breast Cancer Res. 2022 09 02; 24(1):58.
Score: 0.007
-
Endocrine Therapy Response and 21-Gene Expression Assay for Therapy Guidance in HR+/HER2- Early Breast Cancer. J Clin Oncol. 2022 08 10; 40(23):2557-2567.
Score: 0.007
-
De-escalated neoadjuvant pertuzumab plus trastuzumab therapy with or without weekly paclitaxel in HER2-positive, hormone receptor-negative, early breast cancer (WSG-ADAPT-HER2+/HR-): survival outcomes from a multicentre, open-label, randomised, phase 2 trial. Lancet Oncol. 2022 05; 23(5):625-635.
Score: 0.007
-
Modification to Systemic Anticancer Therapy at the Start of the COVID-19 Pandemic and its Overall Impact on Survival Outcomes in Patients with Colorectal Cancer. Clin Colorectal Cancer. 2022 06; 21(2):e117-e125.
Score: 0.007
-
TP53 mutations are associated with primary endocrine resistance in luminal early breast cancer. Cancer Med. 2021 12; 10(23):8581-8594.
Score: 0.007
-
Inhibition of WEE1 Is Effective in TP53- and RAS-Mutant Metastatic Colorectal Cancer: A Randomized Trial (FOCUS4-C) Comparing Adavosertib (AZD1775) With Active Monitoring. J Clin Oncol. 2021 11 20; 39(33):3705-3715.
Score: 0.007
-
The effect of continuous venovenous hemodiafiltration on amino acid delivery, clearance, and removal in children. Pediatr Nephrol. 2022 02; 37(2):433-441.
Score: 0.007
-
The use of breast ultrasound for prediction of pathologic complete response in different subtypes of early breast cancer within the WSG-ADAPT subtrials. Breast. 2021 Oct; 59:58-66.
Score: 0.007
-
Novel scoring system for determining fetal candidacy for prenatal intervention for severe congenital lower urinary tract obstruction. Eur J Obstet Gynecol Reprod Biol. 2021 Jul; 262:118-123.
Score: 0.007
-
Immune cell composition and functional marker dynamics from multiplexed immunohistochemistry to predict response to neoadjuvant chemotherapy in the WSG-ADAPT-TN trial. J Immunother Cancer. 2021 05; 9(5).
Score: 0.007
-
Magnetic resonance imaging and ultrasound for prediction of residual tumor size in early breast cancer within the ADAPT subtrials. Breast Cancer Res. 2021 03 18; 23(1):36.
Score: 0.006
-
The Impact of Changes in Service Delivery in Patients With Colorectal Cancer During the Initial Phase of the COVID-19 Pandemic. Clin Colorectal Cancer. 2021 06; 20(2):e120-e128.
Score: 0.006
-
Early Adaptation of Colorectal Cancer Cells to the Peritoneal Cavity Is Associated with Activation of "Stemness" Programs and Local Inflammation. Clin Cancer Res. 2021 02 15; 27(4):1119-1130.
Score: 0.006
-
Natural genetic variation in Stim1 creates stroke in the spontaneously hypertensive rat. Genes Immun. 2020 05; 21(3):182-192.
Score: 0.006
-
Neurodevelopmental Outcome in Infants with Lower Urinary Tract Obstruction Based on Different Degrees of Severity. Fetal Diagn Ther. 2020; 47(8):587-596.
Score: 0.006
-
Nephronophthisis due to a novel DCDC2 variant in a patient from African-Caribbean descent: A case report. Am J Med Genet A. 2020 03; 182(3):527-531.
Score: 0.006
-
Differences between membranoproliferative glomerulonephritis types I and III in long-term response to an alternate-day prednisone regimen. Am J Kidney Dis. 1999 Dec; 34(6):1022-32.
Score: 0.006
-
Characterization of the renal phenotype in RMND1-related mitochondrial disease. Mol Genet Genomic Med. 2019 12; 7(12):e973.
Score: 0.006
-
Outcome of fetuses with lower urinary tract obstruction and normal amniotic fluid volume in second trimester of pregnancy. Ultrasound Obstet Gynecol. 2019 Oct; 54(4):500-505.
Score: 0.006
-
Functional Outcome Following Stroke Thrombectomy in Clinical Practice. Stroke. 2019 09; 50(9):2500-2506.
Score: 0.006
-
Role of Emergency Laparoscopic Colectomy for Colorectal Cancer: A Population-based Study in England. Ann Surg. 2019 07; 270(1):172-179.
Score: 0.006
-
Efficacy of deescalated chemotherapy according to PAM50 subtypes, immune and proliferation genes in triple-negative early breast cancer: Primary translational analysis of the WSG-ADAPT-TN trial. Int J Cancer. 2020 01 01; 146(1):262-271.
Score: 0.006
-
Health-related quality of life in glomerular disease. Kidney Int. 2019 05; 95(5):1209-1224.
Score: 0.006
-
CureGN Study Rationale, Design, and Methods: Establishing a Large Prospective Observational Study of Glomerular Disease. Am J Kidney Dis. 2019 02; 73(2):218-229.
Score: 0.006
-
Systematic evaluation of stroke thrombectomy in clinical practice: The German Stroke Registry Endovascular Treatment. Int J Stroke. 2019 06; 14(4):372-380.
Score: 0.005
-
Peritoneal dialysis catheter outcomes in infants initiating peritoneal dialysis for end-stage renal disease. BMC Nephrol. 2018 09 14; 19(1):231.
Score: 0.005
-
Does deep inspiration breath-hold prolong life? Individual risk estimates of ischaemic heart disease after breast cancer radiotherapy. Radiother Oncol. 2019 02; 131:202-207.
Score: 0.005
-
Surgical interventions and anesthesia in the 1st year of life for lower urinary tract obstruction. J Pediatr Surg. 2019 Apr; 54(4):820-824.
Score: 0.005
-
Comparison of Neoadjuvant Nab-Paclitaxel+Carboplatin vs Nab-Paclitaxel+Gemcitabine in Triple-Negative Breast Cancer: Randomized WSG-ADAPT-TN Trial Results. J Natl Cancer Inst. 2018 06 01; 110(6):628-637.
Score: 0.005
-
Effect of public reporting of surgeons' outcomes on patient selection, "gaming," and mortality in colorectal cancer surgery in England: population based cohort study. BMJ. 2018 May 02; 361:k1581.
Score: 0.005
-
Therapeutic Plasma Exchange Use in Pediatric Neurologic Disorders at a Tertiary Care Center: A 10-Year Review. J Child Neurol. 2018 02; 33(2):140-145.
Score: 0.005
-
Chemotherapy and Post-traumatic Stress in the Causation of Cognitive Dysfunction in Breast Cancer Patients. J Natl Cancer Inst. 2017 10 01; 109(10).
Score: 0.005
-
Regional citrate anticoagulation for continuous renal replacement therapy in pediatric patients with liver failure. PLoS One. 2017; 12(8):e0182134.
Score: 0.005
-
Lower urinary tract obstruction: fetal intervention based on prenatal staging. Pediatr Nephrol. 2017 10; 32(10):1871-1878.
Score: 0.005
-
De-Escalation Strategies in Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Early Breast Cancer (BC): Final Analysis of the West German Study Group Adjuvant Dynamic Marker-Adjusted Personalized Therapy Trial Optimizing Risk Assessment and Therapy Response Prediction in Early BC HER2- and Hormone Receptor-Positive Phase II Randomized Trial-Efficacy, Safety, and Predictive Markers for 12 Weeks of Neoadjuvant Trastuzumab Emtansine With or Without Endocrine Therapy (ET) Versus Trastuzumab Plus ET. J Clin Oncol. 2017 Sep 10; 35(26):3046-3054.
Score: 0.005
-
Are ultrasound renal aspects associated with urinary biochemistry in fetuses with lower urinary tract obstruction? Prenat Diagn. 2016 Dec; 36(13):1206-1210.
Score: 0.005
-
Fetal lower urinary tract obstruction: proposal for standardized multidisciplinary prenatal management based on disease severity. Ultrasound Obstet Gynecol. 2016 Oct; 48(4):476-482.
Score: 0.005
-
Whole-exome sequencing in the molecular diagnosis of individuals with congenital anomalies of the kidney and urinary tract and identification of a new causative gene. Genet Med. 2017 04; 19(4):412-420.
Score: 0.005
-
Factors associated with fetal shunt dislodgement in lower urinary tract obstruction. Prenat Diagn. 2016 Aug; 36(8):720-5.
Score: 0.005
-
Nephrotic syndrome accompanying familial hemophagocytic syndrome. J Pediatr Hematol Oncol. 1996 May; 18(2):195-7.
Score: 0.005
-
Prevalence of BRCA1/2 germline mutations in 21 401 families with breast and ovarian cancer. J Med Genet. 2016 07; 53(7):465-71.
Score: 0.005
-
Clinically assessed posttraumatic stress in patients with breast cancer during the first year after diagnosis in the prospective, longitudinal, controlled COGNICARES study. Psychooncology. 2017 01; 26(1):74-80.
Score: 0.005
-
The Pharmacokinetics of Intradialytic Administration of Eculizumab in an Infant. Am J Kidney Dis. 2015 Dec; 66(6):1105-6.
Score: 0.004
-
Who may benefit from preoperative breast MRI? A single-center analysis of 1102 consecutive patients with primary breast cancer. Breast Cancer Res Treat. 2015 Oct; 153(3):531-7.
Score: 0.004
-
Elucidating pretreatment cognitive impairment in breast cancer patients: the impact of cancer-related post-traumatic stress. J Natl Cancer Inst. 2015 Jul; 107(7).
Score: 0.004
-
Using a non-invasive method in chronic hemodialysis pediatric patients to estimate hemoglobin. Pediatr Nephrol. 2015 Apr; 30(4):661-4.
Score: 0.004
-
Immunoglobulin locus associates with serum IgG levels and albuminuria. J Am Soc Nephrol. 2011 May; 22(5):881-9.
Score: 0.003
-
Cholera toxin inhibits IL-12 production and CD8alpha+ dendritic cell differentiation by cAMP-mediated inhibition of IRF8 function. J Exp Med. 2009 Jun 08; 206(6):1227-35.
Score: 0.003
-
Association of the complement factor H Y402H polymorphism with cardiovascular disease is dependent upon hypertension status: The ARIC study. Am J Hypertens. 2008 May; 21(5):533-8.
Score: 0.003
-
Cryptococcosis associated with crescentic glomerulonephritis. Pediatr Nephrol. 2008 May; 23(5):827-30.
Score: 0.003
-
Pediatric hypertension: diagnosis, evaluation, management, and treatment for the primary care physician. Curr Probl Pediatr Adolesc Health Care. 2005 Aug; 35(7):262-94.
Score: 0.002
-
Anti-mouse mesangial cell serum induces acute glomerulonephropathy in mice. Nephron Exp Nephrol. 2003; 93(3):e92-106.
Score: 0.002